Advertisement

ADVERTISEMENT

Embolic Protection

Brain Health for Cardiology
Protecting the Brain in TAVR
03/05/2017

Cath Lab Digest talks with Daryl R. Gress, MD, Professor - Department of Neurological Sciences, Neurointensivist - Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska.

Cath Lab Digest talks with Daryl R. G...
The TAVR procedure risks relate to embolic material that is dislodged during the procedure, and for the brain, that really is the greatest risk of the procedure. The embolic material can lead to stroke and infarction in the brain.   
The TAVR procedure risks relate to embolic material that is dislodged during the procedure, and for the brain, that really is the greatest risk of the procedure. The embolic material can lead to stroke and infarction in the brain.   
The TAVR procedure risks relate...
03/05/2017
Cath Lab Digest
Calcium Corner
A Look at the SENTINEL Trial: Cerebral Protection in TAVR
01/10/2017

Cath Lab Digest talks with Axel Linke, MD, 
University of Leipzig Heart Center, Leipzig, Germany.

Cath Lab Digest talks with Axel Linke...
We as physicians should be very interested in the promise of a device like Sentinel that is showing potential in reducing brain lesions in TAVR. 
We as physicians should be very interested in the promise of a device like Sentinel that is showing potential in reducing brain lesions in TAVR. 
We as physicians should be very...
01/10/2017
Cath Lab Digest
Lesion Characterization Using Optical Coherence Tomography to Guide Percutaneous Coronary Intervention
04/04/2013
Brian Shaw, DO, Nemalan Selvaraj, DO, and Jon C. George, MD, Division of Interventional Cardiology and Endovascular Medicine, Deborah Heart and Lung Center, Browns Mills, New Jersey
Brian Shaw, DO, Nemalan Selvaraj, DO,...
We present a case of a lesion within a previously placed right coronary artery stent that was determined to be thrombotic in nature, thereby guiding the strategy for percutaneous coronary intervention.
We present a case of a lesion within a previously placed right coronary artery stent that was determined to be thrombotic in nature, thereby guiding the strategy for percutaneous coronary intervention.
We present a case of a lesion...
04/04/2013
Cath Lab Digest
Carotid Artery Stenting: Case Selection, Training Requirements and Recommendations for a Successful Procedure
06/19/2008
Rajesh M. Dave, MD, FACC, FSCAI, Chairman, Endovascular Medicine Pinnacle Health Heart and Vascular Institute Harrisburg Hospital, Harrisburg, Pennsylvania
Rajesh M. Dave, MD, FACC, FSCAI, Chai...
Two carotid artery stent systems consisting of a self-expanding stent and compatible embolic protection filter device have marketing clearance by the United States Food and Drug Administration (FDA). The Guidant Corporation Acculink® Carotid...
Two carotid artery stent systems consisting of a self-expanding stent and compatible embolic protection filter device have marketing clearance by the United States Food and Drug Administration (FDA). The Guidant Corporation Acculink® Carotid...
Two carotid artery stent systems...
06/19/2008
Cath Lab Digest
Feature
Carotid Artery Stenting: Case Selection, Training Requirements and Recommendations for a Successful Procedure
06/19/2008
Rajesh M. Dave, MD, FACC, FSCAI, Chairman, Endovascular Medicine Pinnacle Health Heart and Vascular Institute Harrisburg Hospital, Harrisburg, Pennsylvania
Rajesh M. Dave, MD, FACC, FSCAI, Chai...
Two carotid artery stent systems consisting of a self-expanding stent and compatible embolic protection filter device have marketing clearance by the United States Food and Drug Administration (FDA). The Guidant Corporation Acculink® Carotid...
Two carotid artery stent systems consisting of a self-expanding stent and compatible embolic protection filter device have marketing clearance by the United States Food and Drug Administration (FDA). The Guidant Corporation Acculink® Carotid...
Two carotid artery stent systems...
06/19/2008
Cath Lab Digest
Carotid Stenting: An update
06/19/2008
What are the latest developments in carotid stenting trials and research? In July of this year, Kensey Nash Corporation announced a Board of Directors decision to cease all activities involving the marketing and regulatory approval process...
What are the latest developments in carotid stenting trials and research? In July of this year, Kensey Nash Corporation announced a Board of Directors decision to cease all activities involving the marketing and regulatory approval process...
What are the latest developments...
06/19/2008
Cath Lab Digest
Feature
Carotid Stenting: An update
06/19/2008
What are the latest developments in carotid stenting trials and research? In July of this year, Kensey Nash Corporation announced a Board of Directors decision to cease all activities involving the marketing and regulatory approval process...
What are the latest developments in carotid stenting trials and research? In July of this year, Kensey Nash Corporation announced a Board of Directors decision to cease all activities involving the marketing and regulatory approval process...
What are the latest developments...
06/19/2008
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use